Xenon Pharmaceuticals Inc. · NASDAQ:XENE

Patou Gary exercised options for 2,645 Xenon Pharmaceuticals Inc. shares (Form 4)

Traded Jun 1, 2026 · Filed Jun 3, 2026

On Jun 1, 2026, Patou Gary (Director) exercised options for 2,645 Xenon Pharmaceuticals Inc. shares, leaving 26,218 shares. Filed Jun 3, 2026 (Form 4).

Options exercised
2,645 shares
Holding after
26,218 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 1, 2026Common SharesOption exercise2,64526,218Direct

Source

View original at SEC

Related